Αρχειοθήκη ιστολογίου

Πέμπτη 28 Μαΐου 2020

Acute-on-Chronic Liver Failure
New England Journal of Medicine, Volume 382, Issue 22, Page 2137-2145, May 2020.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Wed May 27, 2020 11:56
Soluble Urokinase Receptor and Acute Kidney Injury
New England Journal of Medicine, Volume 382, Issue 22, Page 2166-2168, May 2020.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Wed May 27, 2020 11:56
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
New England Journal of Medicine, Volume 382, Issue 22, Page 2168-2169, May 2020.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Wed May 27, 2020 11:56
FDA Initiative for Drug Facts Label for Over-the-Counter Naloxone
New England Journal of Medicine, Volume 382, Issue 22, Page 2129-2136, May 2020.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Wed May 27, 2020 11:56
Lung-Cancer Screening and the NELSON Trial
New England Journal of Medicine, Volume 382, Issue 22, Page 2164-2166, May 2020.
Massachusetts Medical Society: New England Journal of Medicine: Table of Contents
Wed May 27, 2020 11:56
Afatinib is active in osteosarcoma in osteosarcoma cell lines
Abstract Purpose Osteosarcoma is the most common bone tumor, mainly affecting adolescents and young adults, and metastatic disease has poor outcomes with a dismal overall survival. Currently, chemotherapy is the standard of care with limited results, finding that new therapies could improve these outcomes. Preclinical and clinical studies have suggested a possible important role of ErbB pathway aberrations in osteosarcoma etiology....
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Survival prediction for patients with non-resectable intrahepatic cholangiocarcinoma undergoing chemotherapy: a retrospective analysis comparing the tumor marker CA 19-9 with cross-sectional imaging
Abstract Purpose Carbohydrate antigen (CA) 19-9 has been established as the main serum marker for patients with intrahepatic cholangiocarcinoma (ICC). The aim of this study was to compare the prognostic value of CA 19-9 changes versus response determined by imaging in patients with ICC undergoing chemotherapy. Methods Between 2003 and...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Knowledge transfer as a tool towards improvement of cancer care in low- and middle-income countries. 6th European Roundtable Meeting (ERTM), June 14th, 2019, Berlin, Germany
Abstract Purpose To identify key factors for the best practice of knowledge transfer from high-income settings to low- and middle-income settings. Results Interactive sessions led to the identification of European learnings that can and should be shared beyond Europe. Furthermore, methods were characterised which may lead to successful...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Use of GoFundMe ® to crowdfund complementary and alternative medicine treatments for cancer
Abstract Purpose Complementary and alternative medicine (CAM) use is common amongst cancer patients. However, there is growing concern about its safety and efficacy. Online crowdfunding campaigns represent a unique avenue to understand the cancer patient’s perspective for using CAM or declining conventional cancer therapy (CCT). Methods ...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Target-based genomic profiling of ctDNA from Chinese non-small cell lung cancer patients: a result of real-world data
Abstract Purpose Approximately 30% of NSCLC patients cannot obtain tissue sample or sufficient tissue sample for molecular subtyping. Cell-free circulating tumor DNA (ctDNA) in plasma is a potential alternative specimen type to assess genomic variants in patients with non-small cell lung cancer (NSCLC). The purpose of this study was to identify the genomic alteration profile of ctDNA in real-world Chinese NSCLC patients. ...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Genome-wide analysis of prognostic-related lncRNAs, miRNAs and mRNAs forming a competing endogenous RNA network in lung squamous cell carcinoma
Abstract Purpose As a type of cancer with the highest morbidity and mortality, lung squamous cell carcinoma (LUSC) has a very poor prognosis. Long-non-coding RNA (lncRNA) has recently attracted attentions because it can play the role of competing endogenous RNA (ceRNA) to inhibit microRNA (miRNA) functions. In this study, we aimed to find prognosis-related lncRNAs, miRNAs and mRNAs and construct a prognosis-related ceRNA network....
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
A quick evaluation method of nosocomial infection risk for cancer hospitals during the COVID-19 pandemic
Abstract Nosocomial infections caused by COVID-19 will result in the immediate closure of the infected medical facility due to the highly contagious nature of COVID-19, further worsening medical shortages. We performed a Delphi consulting study to develop a risk model based on the experience of recently resumed activities in many cancer hospitals in China. Similar method had been used in a Chinese cancer hospital and effectively reduced the nosocomial Infection. We believe that...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Selected ellipticine derivatives, known to target topoisomerase II, suppress the alternative lengthening of telomere (ALT) pathway in telomerase–negative cells
Abstract Background DNA topoisomerase and telomerase enzymes are popular targets of several anti-tumor drugs. Smooth proceeding of telomeric recombination requires Topoisomerase II (Top2), which is involved in telomere-telomere recombination through functioning in relaxation of positive supercoils among the cells adopting telomerase-independent Alternative lengthening of telomere (ALT) pathway. Most of the inhibitors reported...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Impact of successful local ablative bridging therapy prior to liver transplantation on long-term survival in patients with hepatocellular carcinoma in cirrhosis
Abstract Background It has been shown that local ablative procedures enable downsizing, reduce drop-out from the waiting list and improve prognosis after liver transplantation. It is still unclear whether a response to the local ablative therapy is due to a favorable tumor biology or if a real benefit in tumor stabilization exists, particularly in complete pathological response. ...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Risk of second primary cancers in individuals diagnosed with index smoking- and non-smoking- related cancers
Abstract Purpose As the number of cancer survivors in the United States increases, quantifying the risks and burden of second primary cancers (SPCs) among cancer survivors will help develop long-term prevention and surveillance strategies. We describe the risk of developing a SPC among survivors of 10 cancer sites with the highest survival rates in the United States. ...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Protective effect of kava constituents in an in vitro model of oral mucositis
Abstract Purpose Oral mucositis is a debilitating inflammatory disorder observed in patients undergoing active cancer treatment, particularly cancer of the head and neck region. A key pathway believed to be involved in the pathogenesis of oral mucositis is the formation of reactive oxygen species (ROS). The identification of compounds that can inhibit this pathway may therefore be of benefit in treating this disorder. The kava...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells
Abstract Purpose The usual first-line strategy of wild-type EGFR (wtEGFR) non-small cell lung cancer (NSCLC) remains cisplatin-based chemotherapy. However, cisplatin often loses effectiveness because most tumors acquire drug resistance over time. As EGFR is the most important pro-survival/proliferation signal receptor in NSCLC cells, we aimed at investigating whether cisplatin resistance is related to EGFR activation and further...
Journal of Cancer Research and Clinical Oncology
Thu May 28, 2020 14:12
Urinary balantidiasis in a patient with systemic lupus erythematosus and lupus nephritis: a case report
Balantidium coli, a parasitic unicellular ciliate, often causes asymptomatic balantidiasis of the colon, but extraintestinal disease may occur rarely in immunosuppressed individuals. Renal balantidiasis associate...
Journal of Medical Case Reports - Latest Articles
Thu May 28, 2020 03:00
A combined method of oral commissure lifting for perioral rejuvenation in Asians
Publication date: Available online 27 May 2020Source: Journal of Plastic, Reconstructive & Aesthetic SurgeryAuthor(s): Bailin Pan, Runlei Zhao, Siqiao Wu, Hengju Lin, Yan Long, Guang Hao, Jing Chen, Fuhong Nian
British Association of Plastic Surgeons
Thu May 28, 2020 14:01
Free muscle flap coverage as last resort for therapy resistant neuropathic pain in the upper extremity: a long-term retrospective follow-up study.
Publication date: Available online 27 May 2020Source: Journal of Plastic, Reconstructive & Aesthetic SurgeryAuthor(s): Sara van Bekkum, Dirk-Jan J.C. van der Avoort, J. Michiel Zuidam, J. Henk Coert
British Association of Plastic Surgeons
Thu May 28, 2020 14:01
Whole-body magnetic resonance imaging in pediatric oncology — recommendations by the Oncology Task Force of the ESPR
Abstract The purpose of this recommendation of the Oncology Task Force of the European Society of Paediatric Radiology (ESPR) is to indicate reasonable applications of whole-body MRI in children with cancer and to address useful protocols to optimize workflow and diagnostic performance. Whole-body MRI as a radiation-free modality has been increasingly performed over the last two decades, and newer applications, as in screening of children with germ-line mutation cancer-related...
Pediatric Radiology
Thu May 28, 2020 03:00
Imaging of complications following Fontan circulation in children — diagnosis and surveillance
Abstract The Fontan operation is performed for various cardiac lesions with single-ventricle physiology. The survival rate of Fontan patients is increasing for adolescents and young adults, with an expected 30-year survival of >80%. Medical health care providers including specialists in organ systems and pediatric radiologists need to improve their knowledge about the Fontan circulation and the various organ complications to monitor care. In this review the author explains the...
Pediatric Radiology
Thu May 28, 2020 03:00
Education in the time of COVID-19
Pediatric Radiology
Thu May 28, 2020 03:00
Semen quality from patients affected by seminomatous and non-seminomatous testicular tumor.
Related ArticlesSemen quality from patients affected by seminomatous and non-seminomatous testicular tumor. Int Braz J Urol. 2020 May 10;46: Authors: Xavier R, de Carvalho RC, Fraietta R Abstract Testicular cancer is considered a rare disease affecting approximately 1% to 2% of the male population. This neoplasm has a cure rate of over 95%; as a result, a major concern is the future of fertility of carriers from this disease. There are several histological...
Rare Cancers
Thu May 28, 2020 15:02
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
Related ArticlesClinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Mod Pathol. 2020 May 26;: Authors: Chu YH, Dias-Santagata D, Farahani AA, Boyraz B, Faquin WC, Nosé V, Sadow PM Abstract Primary thyroid neoplasms with actionable NTRK rearrangements are rare, and their clinical behavior, histologic characteristics, and molecular landscape are not well understood. We report an institutional series of eleven NTRK-rearranged...
Rare Cancers
Thu May 28, 2020 13:59
PLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review.
Related ArticlesPLZF-RARα, NPM1-RARα, and Other Acute Promyelocytic Leukemia Variants: The PETHEMA Registry Experience and Systematic Literature Review. Cancers (Basel). 2020 May 21;12(5): Authors: Sobas M, Talarn-Forcadell MC, Martínez-Cuadrón D, Escoda L, García-Pérez MJ, Mariz J, Mela-Osorio MJ, Fernández I, Alonso-Domínguez JM, Cornago-Navascués J, Rodríguez-Macias G, Amutio ME, Rodríguez-Medina C, Esteve J, Sokół A, Murciano-Carrillo T, Calasanz MJ, Barrios M, Barragán...
Rare Cancers
Thu May 28, 2020 13:59
Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience.
Related ArticlesClinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience. Cancers (Basel). 2020 May 21;12(5): Authors: Hur JY, Kim JY, Ahn JS, Im YH, Lee J, Kwon M, Park YH Abstract There are few reports of breast cancer patients who carry germline mutations in both germline breast cancer susceptibility genes 1 (gBRCA1) and 2 (gBRCA2). In this study, we analyzed...
Rare Cancers
Thu May 28, 2020 13:59
Tspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner.
Related ArticlesTspan8 Drives Melanoma Dermal Invasion by Promoting ProMMP-9 Activation and Basement Membrane Proteolysis in a Keratinocyte-Dependent Manner. Cancers (Basel). 2020 May 21;12(5): Authors: El Kharbili M, Cario M, Béchetoille N, Pain C, Boucheix C, Degoul F, Masse I, Berthier-Vergnes O Abstract Melanoma is the most aggressive skin cancer with an extremely challenging therapy. The dermal-epidermal junction (DEJ) degradation and subsequent...
Rare Cancers
Thu May 28, 2020 13:59
Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
Related ArticlesMultifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake. Clin Nucl Med. 2020 Mar;45(3):e156-e157 Authors: Parra LA, Swanson SK, Salomao MA, Yang M Abstract We report a case of an adult male patient with multifocal urinary bladder paragangliomas, which were negative on Ga-DOTATATE PET/CT scan, but positive on I-MIBG SPECT/CT scan. While the Ga-DOTA analog PET/CT exhibits superior performance...
Rare Cancers
Thu May 28, 2020 13:59
Treatment challenges in pediatric Cushing's disease: Review of the literature with particular emphasis on predictive factors for the disease recurrence.
Related ArticlesTreatment challenges in pediatric Cushing's disease: Review of the literature with particular emphasis on predictive factors for the disease recurrence. Endocrine. 2019 11;66(2):125-136 Authors: Pasternak-Pietrzak K, Moszczyńska E, Szalecki M Abstract Cushing's disease (CD) is a rare endocrine condition caused by a corticotroph pituitary tumor that produces adrenocorticotropic hormone. The current state of knowledge of CD treatment...
Rare Cancers
Thu May 28, 2020 13:59
Intraductal carcinomas of the salivary glands: systematic review and classification of 93 published cases.
Related ArticlesIntraductal carcinomas of the salivary glands: systematic review and classification of 93 published cases. APMIS. 2020 Mar;128(3):191-200 Authors: Palicelli A Abstract Intraductal carcinomas (IDCs) are rare, not well-characterized salivary gland tumors. A systematic literature review of pure IDCs (without stromal invasion) of low-grade (LG-IDCs) or high-grade (HG-IDCs) was performed: IDCs were classified using the apocrine (AR+/S100-)...
Rare Cancers
Thu May 28, 2020 13:59
Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.
Related ArticlesExposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors. Eur J Immunol. 2019 12;49(12):2245-2251 Authors: Creasy CA, Forget MA, Singh G, Tapia C, Xu M, Stephen B, Sabir S, Meric-Bernstam F, Haymaker C, Bernatchez C, Naing A Abstract The pervasive use of therapeutic antibodies targeting programmed cell death protein 1 (PD-1) to boost anti-tumor immunity has positioned this approach to...
Rare Cancers
Thu May 28, 2020 13:59
ASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward.
Related ArticlesASO Author Reflections: De-escalation of Breast Cancer Surgery-A Leap Forward. Ann Surg Oncol. 2019 12;26(Suppl 3):711-712 Authors: Özkurt E, Golshan M PMID: 31468219 [PubMed - indexed for MEDLINE]
Rare Cancers
Thu May 28, 2020 13:59
Addressing delays in the diagnosis of pheochromocytoma/paraganglioma.
Related ArticlesAddressing delays in the diagnosis of pheochromocytoma/paraganglioma. Expert Rev Endocrinol Metab. 2019 09;14(5):359-363 Authors: Ilias I, Thomopoulos C Abstract Introduction: Pheochromocytomas/paragangliomas (PPG) are rare tumors. In theory the diagnosis of PPG should be straightforward. In clinical practice, however, considerable delays are noted in establishing such a diagnosis. Areas covered: We assess the characteristics of various...
Rare Cancers
Thu May 28, 2020 13:59
Signet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma.
Related ArticlesSignet ring cell colorectal cancer: genomic insights into a rare subpopulation of colorectal adenocarcinoma. Br J Cancer. 2019 09;121(6):505-510 Authors: Korphaisarn K, Morris V, Davis JS, Overman MJ, Fogelman DR, Kee BK, Dasari A, Raghav KPS, Shureiqi I, Trupti M, Wolff RA, Eng C, Menter DG, Hamilton S, Kopetz S Abstract BACKGROUND: Signet ring cell carcinoma (SRCC) is a rare subtype of colorectal cancer (CRC). The aim of this study...
Rare Cancers
Thu May 28, 2020 13:59
A case of checkpoint inhibitor-induced celiac disease.
Related ArticlesA case of checkpoint inhibitor-induced celiac disease. J Immunother Cancer. 2019 08 05;7(1):203 Authors: Alsaadi D, Shah NJ, Charabaty A, Atkins MB Abstract BACKGROUND: Immune checkpoint inhibitors (ICIs) have now become standard of care treatment for many malignancies. ICIs are associated with unique immune mediated adverse events (irAEs) due to dysregulation of immune activation. As treatment with ICIs is becoming more common, rare...
Rare Cancers
Thu May 28, 2020 13:59
Characteristics of metastatic brachial plexopathy in patients with breast cancer.
Related ArticlesCharacteristics of metastatic brachial plexopathy in patients with breast cancer. Support Care Cancer. 2020 Apr;28(4):1913-1918 Authors: Kim J, Jeon JY, Choi YJ, Choi JK, Kim SB, Jung KH, Ahn JH, Kim JE, Seo S Abstract PURPOSE: Brachial plexopathy in cancer patients is a rare but significant complication that causes pain and disability of the upper extremities. Clinical features of breast cancer patients with metastatic brachial plexopathy...
Rare Cancers
Thu May 28, 2020 13:59
Development and validation of a nomogram for prognosis of sinonasal squamous cell carcinoma.
Related ArticlesDevelopment and validation of a nomogram for prognosis of sinonasal squamous cell carcinoma. Int Forum Allergy Rhinol. 2019 09;9(9):1030-1040 Authors: Quan H, Yan L, Zhang H, Zou L, Yuan W, Wang S Abstract BACKGROUND: Sinonasal squamous cell carcinoma (SNSCC) is a rare malignancy with varied outcomes. The aim of this study was to develop a nomogram for predicting survival of patients with SNSCC. METHODS: From the Surveillance,...
Rare Cancers
Thu May 28, 2020 13:59
Clinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma.
Related ArticlesClinical outcomes and prognostic factors in patients with no less than three distant organ system metastases from differentiated thyroid carcinoma. Endocrine. 2019 11;66(2):254-265 Authors: Zhang XY, Sun JW, Qiu ZL, Wang Y, Chen XY, Zhao JH, Luo QY Abstract OBJECTIVES: For patients with differentiated thyroid carcinoma (DTC), distant metastases are commonly identified in the lungs and bones. However, they are relatively rare in other...
Rare Cancers
Thu May 28, 2020 13:59

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου